Uñas de los dedos (débiles o quebradizas)

A double-blind RCT (Sharma et al., 2018, J Altern Complement Med) in 50 subclinical hypothyroid patients showed 600 mg/day ashwagandha root extract for 8 weeks significantly improved TSH (p<0.001), T3 (p=0.003), and T4 (p=0.010) versus placebo. Ashwagandha has been used in Ayurvedic medicine for hormonal disorders including thyroid imbalances for centuries.

Myo-inositol is a second messenger in the TSH signaling pathway and is essential for H2O2 production required for thyroid hormone synthesis. Multiple clinical studies demonstrate that myo-inositol combined with selenium significantly reduces TSH and thyroid autoantibodies in subclinical hypothyroidism and autoimmune thyroiditis. A PubMed-indexed 2021 review from Frontiers in Endocrinology summarizes the mechanistic and clinical evidence.

Iodine is the essential raw material for thyroid hormone (T3 and T4) synthesis, comprising 65% of T4 by weight. Deficiency leads to goiter, elevated TSH, and hypothyroidism. Both deficiency and excess carry risks; adequate intake is foundational to thyroid function and is recognized by WHO and all major endocrine bodies.

Iron is an essential cofactor for thyroperoxidase (TPO), the enzyme that catalyzes iodine organification required for thyroid hormone synthesis; iron deficiency impairs this reaction and is common in hypothyroid patients. Studies confirm higher prevalence of iron deficiency in subclinical hypothyroidism. Correction of iron deficiency has been shown to restore thyroid hormone production.

L-tyrosine is the amino acid substrate from which thyroid hormones T3 and T4 are biosynthesized; TPO iodinates tyrosine residues on thyroglobulin to form iodotyrosines that couple to form T3 and T4. Deficiency of tyrosine or its precursor phenylalanine can theoretically limit thyroid hormone production. Traditionally used as a thyroid support nutrient in naturopathic practice.

Magnesium deficiency is associated with elevated thyroid antibodies and increased Hashimoto's disease risk, and it supports iodine uptake into the thyroid gland. A narrative review published in Cureus identified magnesium as an untapped mineral with potential clinical benefit in HT. Magnesium also reduces overall inflammation relevant to autoimmune thyroiditis.

Methylcobalamin is the bioactive, neurologically active form of vitamin B12 and is the preferred supplemental form for Hashimoto's patients with B12 deficiency, particularly where neurological symptoms are present. B12 deficiency is prevalent in 27% of hypothyroid patients and is compounded by autoimmune gastric involvement in Hashimoto's. Methylcobalamin bypasses the need for conversion from cyanocobalamin.

Nigella sativa (black seed) has been studied in a placebo-controlled RCT specifically in Hashimoto's thyroiditis: 2 g/day for 8 weeks produced approximately 50% reduction in TPO antibodies, significant TSH decrease, and improved T3 levels. Thymoquinone, its primary active compound, exerts anti-inflammatory and immunomodulatory effects relevant to autoimmune thyroid disease.

Selenium is an essential cofactor for selenoprotein-based deiodinases and glutathione peroxidases required for thyroid hormone activation and oxidative protection of thyroid tissue. Multiple meta-analyses of RCTs encompassing over 2,300 Hashimoto's patients demonstrate significant reductions in TPO antibody titers and TSH with supplementation. Typical doses studied are 100–200 µg/day of selenomethionine or sodium selenite.

Selenomethionine is the organic form of selenium most extensively studied in RCTs for Hashimoto's thyroiditis and shows the most consistent reduction in TPO antibodies among selenium forms. Subgroup analyses in meta-analyses confirm selenomethionine at 200 µg/day outperforms inorganic selenium for antibody reduction. It serves as both a selenium delivery vehicle and a source of methionine.

Thymoquinone is the principal bioactive compound of Nigella sativa and is responsible for its anti-inflammatory, antioxidant, and immunomodulatory effects relevant to Hashimoto's thyroiditis. It inhibits NF-κB signaling, reduces pro-inflammatory cytokines, and has shown thyroid-protective effects in animal models of hypothyroidism.

Patients with hypothyroidism have significantly lower serum vitamin B12 levels than healthy controls (MD −60.67 pg/mL; p=0.01), and 27% of hypothyroid patients are B12-deficient, per a 2023 meta-analysis of 64 studies (n=28,597). Shared autoimmune mechanisms (anti-parietal cell antibodies) in Hashimoto's further impair B12 absorption, making supplementation clinically relevant.

Vitamin D deficiency is prevalent in Hashimoto's thyroiditis and is mechanistically linked to impaired VDR-mediated Treg/Th17 immune balance, increasing anti-TPO antibody production. A 2021 meta-analysis of 8 RCTs (n=652) found vitamin D supplementation significantly reduced both TPOAb and TGAb titers in HT patients. Supplementation doses of 2,000–4,000 IU/day for >3 months show the most consistent effects.

Cholecalciferol (vitamin D3) is the most clinically effective form of vitamin D for reducing thyroid autoantibodies in Hashimoto's thyroiditis. A 2021 meta-analysis confirmed that vitamin D3 specifically (not generic vitamin D) significantly reduced TPOAb titers (SMD −1.48; p=0.006) in HT patients. It works by modulating Treg/Th17 immune balance and reducing pro-inflammatory cytokines.

Withanolides are the principal bioactive steroidal lactones of Withania somnifera (ashwagandha) responsible for its thyroid-supporting effects. They are proposed to directly stimulate thyroid hormone synthesis and enhance T4-to-T3 conversion, as evidenced by standardized withanolide-containing extracts showing normalized TSH, T3, and T4 in subclinical hypothyroid RCTs.

Zinc is required for thyroid hormone production, TSH synthesis, and the deiodinase-mediated conversion of T4 to active T3. Low zinc concentrations are associated with hypothyroidism, and a 2015 RCT showed that zinc supplementation (alone or with selenium) significantly increased free T3 and improved thyroid function in hypothyroid patients. Studies typically use 25–30 mg/day.

Bladderwrack (Fucus vesiculosus) is a brown seaweed historically used as a traditional remedy for hypothyroidism due to its high iodine content. It has been recommended since at least the 19th century for goiter and iodine-deficiency hypothyroidism. Its use is appropriate only for iodine-deficiency-driven hypothyroidism, as excess iodine can worsen autoimmune forms.

Guggulsterones have demonstrated thyroid-stimulating effects in animal studies, including increased iodine uptake by the thyroid, enhanced thyroid peroxidase activity, and increased T3 production. No well-designed human RCTs specifically for hypothyroidism have been published. Traditional Ayurvedic formulations such as Kanchanar Guggulu are prescribed for thyroid disorders.

Kelp is a brown seaweed used traditionally as a natural iodine source to address iodine-deficiency hypothyroidism and goiter. As a dietary iodine vehicle, it has been part of thyroid health traditions in Japanese and Western herbal medicine for centuries. Clinical use is restricted to confirmed iodine deficiency, as excess iodine can worsen Hashimoto's.